Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · IEX Real-Time Price · USD
2.380
+0.143 (6.37%)
May 17, 2024, 4:00 PM EDT - Market closed

Can-Fite BioPharma Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Can-Fite BioPharma stock has a target of 18, which predicts an increase of 656.30% from the current stock price of 2.38.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $18 $18 $18 $18
Change +656.30% +656.30% +656.30% +656.30%

Analyst Ratings

According to 1 stock analyst, the rating for CANF is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Dec '23Jan '24Feb '24Mar '24Apr '24May '24
Strong Buy 111111
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$18
Strong Buy Reiterates $18 +656.30% May 9, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$34$18
Strong Buy Maintains $34$18 +656.30% Oct 24, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$34
Strong Buy Reiterates $34 +1,328.57% Jun 2, 2023
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$34
Strong Buy Reiterates $34 +1,328.57% Mar 13, 2023
Aegis Capital
Aegis Capital
Strong Buy
Initiates
n/a
Strong Buy Initiates n/a n/a Jun 24, 2021
More Analyst Ratings

Financial Forecast

Revenue This Year
14.81M
from 743.00K
Increased by 1,893.41%
Revenue Next Year
10.12M
from 14.81M
Decreased by -31.67%
EPS This Year
-4.11
from -3.00
EPS Next Year
-3.85
from -4.11
Year 20192020202120222023202420252026
Revenue
2.03M763.00K853.00K810.00K743.00K14.81M10.12M21.40M
Revenue Growth
-46.81%-62.45%11.80%-5.04%-8.27%1,893.41%-31.67%111.50%
EPS
-42.00-12.00-9.00-3.00-3.00-4.11-3.85-3.85
EPS Growth
--------
No. Analysts -----544
Financial currency is ILS. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202420252026
High 42.6M 17.7M 41.0M
Avg 14.8M 10.1M 21.4M
Low n/a 2.9M 2.9M

Revenue Growth

Revenue Growth 202420252026
High
5,640.1%
19.8%
304.9%
Avg
1,893.4%
-31.7%
111.5%
Low -
-80.5%
-71.5%

EPS Forecast

EPS 202420252026
High -2.07 -1.15 -0.20
Avg -4.11 -3.85 -3.85
Low -5.95 -6.31 -7.22

EPS Growth

EPS Growth 202420252026
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.